CareDx To Participate in the Raymond James & Associates’ 44th Annual Institutional Investors Conference

Rhea-AI Summary

CareDx, Inc. (NASDAQ: CDNA), known as The Transplant Company™, announced its participation in the Raymond James & Associates’ 44th Annual Institutional Investors Conference. The presentation is scheduled for Monday, March 6, 2023, at 4:35 PM ET. Investors can access the webcast by visiting CareDx's investor relations page at investors.caredxinc.com. CareDx is a leader in precision medicine solutions, offering innovative testing services and digital healthcare solutions for transplant patients throughout their journey.

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the Raymond James & Associates’ 44^th Annual Institutional Investors Conference.

CareDx’s management is scheduled to present at the Raymond James & Associates’ 44^th Annual Institutional Investors Conference on Monday, March 6^th, 2023, at 4:35 PM ET. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230302005345/en/

Investor Relations

Greg Chodaczek

investor@CareDx.com

Source: CareDx, Inc.

FAQ

When will CareDx present at the Raymond James Investors Conference?

CareDx will present at the Raymond James & Associates’ 44th Annual Institutional Investors Conference on Monday, March 6, 2023, at 4:35 PM ET.

How can I listen to the CareDx presentation at the conference?

You can listen to the CareDx presentation by visiting the investor relations section of their website at investors.caredxinc.com.

What is CareDx's focus as a company?

CareDx specializes in discovery, development, and commercialization of healthcare solutions for transplant patients and their caregivers.

What type of healthcare solutions does CareDx provide?

CareDx provides testing services, products, and digital healthcare solutions that support transplant patients before and after their procedures.

What stock symbol does CareDx operate under?

CareDx operates under the stock symbol CDNA on the NASDAQ.